A patient with diffuse large B-cell non-Hodgkin's lymphoma and AA type amyloidosis. 2008

O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
Department of Hematology, Dokuz Eylul University, School of Medicine, Izmir, Turkey.

AA-type amyloidosis is a consequence of a long-standing systemic inflammation and is not associated with a monoclonal protein or clonal bone marrow plasma cells. Proinflammatory cytokines such as interleukin (IL)1, IL-6, and tumor necrosis factor (TNF) stimulate the synthesis of serum amyloid A during inflammation. Although the association of non-Hodgkin's lymphoma (NHL) with AL-type amyloidosis is well known and patients with Hodgkin's lymphoma with AA amyloidosis have been described, AA-type amyloidosis with NHL is extremely infrequent. We report a case of amyloidosis associated with NHL that subsided during R-CHOP chemotherapy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000685 Serum Amyloid A Protein An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS. Amyloid Protein SAA,Amyloid Serum Protein SAA,Serum A Related Protein,Amyloid A Precursor,Amyloid A Protein,Amyloid A Protein-Related Serum Component,Amyloid Fibril Protein AA,Amyloid Protein AA,Amyloid Protein AA Precursor,Amyloid-Related Serum Protein (SAA),Serum Amyloid A,Serum Amyloid Protein A,Amyloid A Protein Related Serum Component
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D016403 Lymphoma, Large B-Cell, Diffuse Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. Diffuse Large B-Cell Lymphoma,Diffuse, Large B-Cell, Lymphoma,Histiocytic Lymphoma, Diffuse,Lymphoma, Histiocytic, Diffuse,Diffuse Large-Cell Lymphoma,Histiocytic Lymphoma,Large Lymphoid Lymphoma, Diffuse,Large-Cell Lymphoma, Diffuse,Lymphoma, Diffuse Large-Cell,Lymphoma, Histiocytic,Lymphoma, Large Cell, Diffuse,Lymphoma, Large Lymphoid, Diffuse,Lymphoma, Large-Cell, Diffuse,Diffuse Histiocytic Lymphoma,Diffuse Histiocytic Lymphomas,Diffuse Large B Cell Lymphoma,Diffuse Large Cell Lymphoma,Diffuse Large-Cell Lymphomas,Histiocytic Lymphomas,Large Cell Lymphoma, Diffuse,Lymphoma, Diffuse Histiocytic,Lymphoma, Diffuse Large Cell

Related Publications

O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
June 2005, Clinical evidence,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
June 2006, Clinical evidence,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
August 2004, Human pathology,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
January 1993, Acta haematologica,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
May 2001, British journal of haematology,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
March 2002, Leukemia & lymphoma,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
December 2020, Molecular genetics and metabolism reports,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
September 2004, Leukemia & lymphoma,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
December 2006, Experimental oncology,
O Piskin, and I Alacacioglu, and S Ozkal, and M A Ozcan, and F Demirkan, and G Hayri Ozsan, and A Kargi, and B Undar
January 2013, The Indian journal of chest diseases & allied sciences,
Copied contents to your clipboard!